Adjuvant trastuzumab improves survival in early breast cancer

被引：1
|
作者：
Brower, Vicki
机构：
来源：
LANCET ONCOLOGY | 2014年 / 15卷 / 13期
关键词：
D O I：
10.1016/S1470-2045(14)71110-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E589 / E589
页数：1
相关论文
共 50 条
  • [21] Cardiac safety of trastuzumab as adjuvant treatment for Japanese patients with early breast cancer
    Mikiya Ishihara
    Hirofumi Mukai
    Shunji Nagai
    Toru Mukohara
    International Journal of Clinical Oncology, 2009, 14 : 431 - 435
  • [22] Efficacy of short-course adjuvant trastuzumab in early stage breast cancer
    Saifo, M.
    Nikoula, M.
    CANCER RESEARCH, 2019, 79 (04)
  • [23] Trastuzumab for early breast cancer
    Smith, IE
    LANCET, 2006, 367 (9505): : 107 - 107
  • [24] Trastuzumab in early breast cancer
    Ismaili, Nabil
    Elmajjaoui, Sanaa
    Tahri, Ali
    Benjaafar, Noureddine
    Errihani, Hassan
    Belbaraka, Rhizlane
    PRESSE MEDICALE, 2013, 42 (7-8): : 1069 - 1080
  • [25] Ongoing adjuvant trials with trastuzumab in breast cancer
    Tan, AR
    Swain, SM
    SEMINARS IN ONCOLOGY, 2003, 30 (05) : 54 - 64
  • [26] Trastuzumab for early breast cancer
    Bryant, J
    Geyer, CE
    LANCET, 2006, 367 (9512): : 728 - 728
  • [27] Trastuzumab plus chemotherapy improves survival in early-stage HER2-positive breast cancer patients
    不详
    ONCOLOGY-NEW YORK, 2005, 19 (07): : 851 - +
  • [28] Trastuzumab improves survival, outcomes of HER2-positive breast cancer patients
    不详
    FORMULARY, 2006, 41 (03) : 146 - +
  • [29] COST-EFFECTIVENESS OF ADJUVANT TRASTUZUMAB FOR EARLY BREAST CANCER IN ASIA: A SYSTEMATIC REVIEW
    Rafar, Abdul N. R.
    Neoh, C. F.
    Othman, M. F.
    Hong, Y. H.
    VALUE IN HEALTH, 2018, 21 : S14 - S14
  • [30] Adjuvant trastuzumab and vinorelbine for early-stage HER2+breast cancer
    McLaughlin, Shannon
    Nakajima, Erika
    Bar, Yael
    Hutchinson, Jennifer A. A.
    Shin, Jennifer
    Moy, Beverly
    Isakoff, Steven J. J.
    Bardia, Aditya
    Kuter, Irene
    Spring, Laura M. M.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
12345